Article ID Journal Published Year Pages File Type
8242081 International Journal of Radiation Oncology*Biology*Physics 2007 8 Pages PDF
Abstract
Conclusion: Cevimeline was well tolerated by patients with xerostomia after radiotherapy for head and neck cancer, and oral administration of 30-45 mg of cevimeline three times daily increased unstimulated salivary flow.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Cevimeline for the Treatment of Postirradiation Xerostomia in Patients With Head and Neck Cancer
Authors
, , , , , , , , , , , , ,